PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia · Delayed Price · Currency is IDR 163.00
0.00 (0.00%)
Sep 2, 2026, 3:07 PM WIB
IDX:LABS Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 10,690 | 13,507 | 2,952 | 2,190 | 2,834 | 308.25 |
Depreciation & Amortization | 11,984 | 12,879 | 12,399 | 9,892 | 9,270 | 8,077 |
Other Operating Activities | -9,853 | -3,494 | -29,032 | -26,909 | -27,151 | -29,016 |
Operating Cash Flow | 13,472 | 22,892 | -13,680 | -14,828 | -15,047 | -20,631 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -18,030 | -14,210 | -6,809 | -19,405 | -3,280 | -11,710 |
Sale of Property, Plant & Equipment | 238.99 | 331.02 | 392.84 | 240.23 | 5,147 | 1,316 |
Cash Acquisitions | -10.42 | -10.42 | - | - | - | - |
Sale (Purchase) of Intangibles | -357.29 | -357.29 | -438.35 | -6,147 | - | - |
Investment in Securities | - | - | - | 4,404 | -2,400 | - |
Other Investing Activities | - | - | - | -713.06 | -4,511 | - |
Investing Cash Flow | -18,159 | -14,247 | -6,855 | -21,621 | -5,044 | -10,394 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 763.65 | 2,651 | 2,759 | - | - |
Long-Term Debt Issued | - | - | - | 18,863 | 18,563 | 33,968 |
Total Debt Issued | 763.65 | 763.65 | 2,651 | 21,622 | 18,563 | 33,968 |
Long-Term Debt Repaid | - | -10,797 | -11,336 | -547.47 | -44,647 | -303.61 |
Net Debt Issued (Repaid) | -5,683 | -10,034 | -8,685 | 21,075 | -26,085 | 33,665 |
Issuance of Common Stock | - | - | 71,400 | 18,163 | 35,405 | - |
Other Financing Activities | - | - | -3,243 | - | - | - |
Financing Cash Flow | -5,683 | -10,034 | 59,472 | 39,238 | 9,320 | 33,665 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -10,370 | -1,389 | 38,937 | 2,789 | -10,770 | 2,640 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4,558 | 8,681 | -20,490 | -34,233 | -18,327 | -32,341 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2.19% | 4.36% | -13.88% | -25.04% | -19.65% | -24.88% |
Free Cash Flow Per Share | -1.15 | 2.20 | -5.19 | -14.54 | - | - |
Levered Free Cash Flow | -4,038 | 4,534 | -41,257 | -34,775 | -22,351 | - |
Unlevered Free Cash Flow | -3,281 | 5,313 | -39,357 | -33,430 | -21,380 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1,067 | 1,245 | 3,041 | 2,153 | 1,554 | 112.31 |
Cash Income Tax Paid | 7,040 | 14,126 | 9,777 | 7,066 | 4,485 | 8,419 |